头颈部动脉支架植入围手术期患者血清NETs标志物的动态变化

doi:10.3969/j.issn.1673-5765.2025.09.009

中国卒中杂志 ›› 2025, Vol. 20 ›› Issue (9): 1137-1145.DOI: 10.3969/j.issn.1673-5765.2025.09.009

头颈部动脉支架植入围手术期患者血清NETs标志物的动态变化

李涛^1*，吴宇伦^1，2*，王小雅¹，李也¹，陆家梁¹，路子微¹，党美娟¹，赵莉莉¹，坚雅婷¹，王何莹¹，张磊¹，卜宁¹，李雯娴¹，樊洪¹，张桂莲¹（*第一作者）

1 西安 710004 西安交通大学第二附属医院神经内科
2 西安市第三医院神经内科

收稿日期:2025-01-20 修回日期:2025-09-05 接受日期:2025-09-08 出版日期:2025-09-20 发布日期:2025-09-20
通讯作者: 张桂莲 zhgl_2006@126.com
基金资助:
四大慢病重大专项（2023ZD0505400）
国家自然科学基金（81971116）

Dynamic Changes in Serum NETs Markers during the Perioperative Period in Patients Undergoing Head and Neck Arterial Stent Implantation

LI Tao1^*, WU Yulun^1,2*, WANG Xiaoya¹, LI Ye1, LU Jialiang¹, LU Ziwei¹, DANG Meijuan¹, ZHAO Lili¹, JIAN Yating¹, WANG Heying¹, ZHANG Lei¹, BU Ning¹, LI Wenxian¹, FAN Hong¹, ZHANG Guilian¹ (*contributed equally)

1 Department of Neurology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China
2 Department of Neurology, Xi’an No.3 Hospital, Xi’an, 710018, China

Received:2025-01-20 Revised:2025-09-05 Accepted:2025-09-08 Online:2025-09-20 Published:2025-09-20
Contact: ZHANG Guilian, E-mail: zhgl_2006@126.com

摘要/Abstract

摘要： 目的探讨头颈部动脉支架植入后血清中性粒细胞外陷阱（neutrophil extracellular traps，NETs）标志物瓜氨酸化组蛋白3（citrullinated histone 3，cit-H3）及髓过氧化物酶（myeloperoxidase，MPO）水平随时间变化的规律。
方法前瞻性连续纳入因头颈部动脉粥样硬化性大动脉狭窄行支架植入术的患者，分别于术前空腹24 h内，术后6、12、24、48 h采集患者静脉血，测定血清cit-H3及MPO水平。采用经Greenhouse-Geisser校正的单因素重复测量方差分析，比较患者围手术期不同时间点血清cit-H3及MPO水平的动态变化趋势。根据支架植入部位（颅内 vs. 颅外）、支架植入数目（1个 vs. 2个）、责任血管是否为症状性狭窄，以及手术时脑梗死是否处于急性期（病程≤14 d），对血清cit-H3及MPO水平的变化进行亚组分析。
结果本研究共纳入48例患者，平均年龄为（61.8±8.4）岁，男性42例（87.5%）。在整体患者中，血清cit-H3在术前及术后6、12、24、48 h的水平分别为（54.50±6.48）ng/mL、（56.73±6.50）ng/mL、（71.27±7.35）ng/mL、（53.53±17.35）ng/mL和（52.22±5.45）ng/mL；血清MPO在术前及术后6、12、24、48 h的水平分别为（25.45±6.67）ng/mL、（26.29±6.75）ng/mL、（28.28±7.68）ng/mL、（31.55±9.09）ng/mL和（28.68±7.61）ng/mL，两者术后水平均呈现先升高后降低趋势，整体差异均具有统计学意义（P=0.002；P=0.022）。颅外及颅内支架亚组、1个及2个支架亚组、症状性狭窄亚组及非急性期亚组的血清cit-H3水平均于术后12 h达到峰值。颅内支架亚组的血清MPO水平于术后12 h达到峰值，2个支架亚组、症状性狭窄亚组及非急性期亚组的血清MPO水平均于术后24 h达到峰值。
结论头颈部动脉支架植入术后48 h内，血清NETs标志物cit-H3和MPO水平呈现先升高后恢复至术前水平的变化趋势，这种趋势在症状性狭窄患者中更显著。

文章导读： 本研究通过连续监测头颈部动脉支架植入围手术期患者的血清NETs标志物cit-H3和MPO水平，发现NETs活性在支架植入术后12～24 h出现升高趋势。在该时间段内对NETs相关病理机制进行干预，或可改善头颈部动脉支架植入术后患者的临床预后。

关键词: 头颈部动脉支架植入; 髓过氧化物酶; 瓜氨酸化组蛋白3

Abstract: Objective To explore the dynamic changes over time in serum levels of neutrophil extracellular traps (NETs) markers—citrullinated histone 3 (cit-H3) and myeloperoxidase (MPO)—after head and neck arterial stent implantation.
Methods Patients with atherosclerotic stenosis of the head and neck arteries who underwent stent implantation were prospectively and consecutively enrolled. Venous blood samples were collected from the patients within 24 hours of fasting before surgery, and at 6, 12, 24, and 48 hours after surgery to measure serum cit-H3 and MPO levels. One-way repeated measures analysis of variance with Greenhouse-Geisser correction was used to compare the dynamic changes in serum cit-H3 and MPO levels across different perioperative time points. Subgroup analyses of the changes in serum cit-H3 and MPO levels were conducted based on stent implantation site (intracranial vs. extracranial), number of stents implanted (1 vs. 2), whether the responsible vessel had symptomatic stenosis, and whether cerebral infarction was in the acute phase (disease duration≤14 days) at the time of surgery.
Results A total of 48 patients were enrolled in this study with a mean age of (61.8±8.4) years, including 42 males (87.5%). Among all patients, the serum cit-H3 levels before surgery and at 6, 12, 24, and 48 hours after surgery were (54.50±6.48) ng/mL, (56.73±6.50) ng/mL, (71.27±7.35) ng/mL, (53.53±17.35) ng/mL, and (52.22±5.45) ng/mL, respectively. The serum MPO levels at the corresponding time points were (25.45±6.67) ng/mL, (26.29±6.75) ng/mL, (28.28±7.68) ng/mL, (31.55±9.09) ng/mL, and (28.68±7.61) ng/mL, respectively. Both markers showed a trend of increasing first and then decreasing, with statistically significant overall differences (P=0.002 for cit-H3; P=0.022 for MPO). In the extracranial and intracranial stent subgroups, the single and double stent subgroups, the symptomatic stenosis subgroup, and the non-acute phase subgroup, the serum cit-H3 levels peaked at 12 hours after surgery. The serum MPO levels peaked at 12 hours after surgery in the intracranial stent subgroup. However, in the double stent subgroup, the symptomatic stenosis subgroup, and the non-acute phase subgroup, the serum MPO levels peaked at 24 hours after surgery.
Conclusions Within 48 hours after head and neck artery stent implantation, the serum levels of NETs markers cit-H3 and MPO showed an initial increase followed by a gradual return to preoperative levels. This trend was more pronounced in patients with symptomatic arterial stenosis.

Key words: Head and neck artery stent implantation; Myeloperoxidase; Citrullinated histone 3

中图分类号:

李涛, 吴宇伦, 王小雅, 李也, 陆家梁, 路子微, 党美娟, 赵莉莉, 坚雅婷, 王何莹, 张磊, 卜宁, 李雯娴, 樊洪, 张桂莲. 头颈部动脉支架植入围手术期患者血清NETs标志物的动态变化[J]. 中国卒中杂志, 2025, 20(9): 1137-1145.

LI Tao, WU Yulun, WANG Xiaoya, LI Ye, LU Jialiang, LU Ziwei, DANG Meijuan, ZHAO Lili, JIAN Yating, WANG Heying, ZHANG Lei, BU Ning, LI Wenxian, FAN Hong, ZHANG Guilian. Dynamic Changes in Serum NETs Markers during the Perioperative Period in Patients Undergoing Head and Neck Arterial Stent Implantation[J]. Chinese Journal of Stroke, 2025, 20(9): 1137-1145.

参考文献

[1] ABBASI M，ARTURO LARCO J，MEREUTA M O，et al. Diverse thrombus composition in thrombectomy stroke patients with longer time to recanalization[J/OL]. Thromb Res，2022，209：99-104[2025-05-16]. https://doi.org/10.1016/j.thromres.2021.11.018.
[2] FANG H J，BO Y F，HAO Z F，et al. A promising frontier：targeting NETs for stroke treatment breakthroughs[J/OL]. Cell Commun Signal，2024，22（1）：238[2025-05-16]. https://doi.org/10.1186/s12964-024-01563-4.
[3] CAO J Y，ROTH S，ZHANG S J，et al. DNA-sensing inflammasomes cause recurrent atherosclerotic stroke[J]. Nature，2024，633（8029）：433-441.
[4] JOLUGBO P，ARIËNS R A S. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke[J]. Stroke，2021，52（3）：1131-1142.
[5] JIANG H，ZHANG H M，YANG Y，et al. Associations of myeloperoxidase，interleukin-17A and heparin-binding EGF-like growth factor levels with in-stent restenosis after percutaneous coronary intervention：a single-centre case-control study in China[J/OL]. BMJ Open，2020，10（11）：e039405[2025-05-16]. https://doi.org/10.1136/bmjopen-2020-039405.
[6] ZHANG S H，GUO M F，LIU Q Z，et al. Neutrophil extracellular traps induce thrombogenicity in severe carotid stenosis[J]. Immun Inflamm Dis，2021，9（3）：1025-1036.
[7] SHIMONAGA K，MATSUSHIGE T，TAKAHASHI H，et al. Peptidylarginine deiminase 4 as a possible biomarker of plaque instability in carotid artery stenosis[J/OL]. J Stroke Cerebrovasc Dis，2021，30（7）：105816[2025-05-16]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105816.
[8] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组，中华医学会神经病学分会神经血管介入协作组. 中国缺血性脑血管病血管内介入诊疗指南2015[J]. 中华神经科杂志，2015，48（10）：830-837.
Chinese Society of Neurology，Chinese Stroke Society，Neurovascular Intervention Group of Chinese Society of Neurology. Guidelines for endovascular diagnosis and treatment of ischemic cerebrovascular disease in China 2015[J]. Chin J Neurol，2015，48（10）：830-837.
[9] QUINN M，ZHANG R Y K，BELLO I，et al. Myeloperoxidase as a promising therapeutic target after myocardial infarction[J/OL]. Antioxidants（Basel），2024，13（7）：788[2025-05-16]. https://doi.org/10.3390/antiox13070788.
[10] PAPAYANNOPOULOS V，METZLER K D，HAKKIM A，et al. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps[J]. J Cell Biol，2010，191（3）：677-691.
[11] WARD A O，ANGELINI G D，CAPUTO M，et al. NF-κB inhibition prevents acute shear stress-induced inflammation in the saphenous vein graft endothelium[J/OL]. Sci Rep，2020，10：15133[2025-05-16]. https://doi.org/10.1038/s41598-020-71781-6.
[12] AKSU U，GULCU O，AKSAKAL E，et al. The association between CRP/albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction[J/OL]. J Clin Lab Anal，2019，33（4）：e22848[2025-05-16]. https://doi.org/10.1002/jcla.22848.
[13] TSOUROUKTSOGLOU T D，WARNATSCH A，IOANNOU M，et al. Histones，DNA，and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4[J/OL]. Cell Rep，2020，31（5）：107602[2025-05-16]. https://doi.org/10.1016/j.celrep.2020.107602.
[14] BADACZ R，PODOLEC J，PRZEWLOCKI T，et al. The role of chemokine CCL5/RANTES and metalloproteinase-9 as inflammatory modulators in symptomatic internal carotid artery stenosis[J]. J Physiol Pharmacol，2019，70（4）：545-555.
[15] HUANG Y X，ZHANG X J，ZHANG C，et al. Edaravone dexborneol downregulates neutrophil extracellular trap expression and ameliorates blood-brain barrier permeability in acute ischemic stroke[J/OL]. Mediators Inflamm，2022，2022：3855698[2025-05-16]. https://doi.org/10.1155/2022/3855698.
[16] AN Z J，LI J W，YU J B，et al. Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages[J]. Cell Cycle，2019，18（21）：2928-2938.
[17] AMINAN A，BOUDJELTIA K Z，BABAR S，et al. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction[J]. Eur J Intern Med，2009，20（5）：527-532.

头颈部动脉支架植入围手术期患者血清NETs标志物的动态变化

Dynamic Changes in Serum NETs Markers during the Perioperative Period in Patients Undergoing Head and Neck Arterial Stent Implantation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	刘丽旭. 融合·闭环·精准：神经调控技术重塑卒中康复[J]. 中国卒中杂志, 2025, 20(9): 1073-1077.
[2]	王瑶, 李雨涵, 陈小刚. 混合脑机接口-功能性电刺激运动康复系统的构建与验证[J]. 中国卒中杂志, 2025, 20(9): 1079-1086.
[3]	夏小茜, 康晓宇, 贾凌云, 王倩惠, 张琳瑶, 张若晴, 王艺铮, 吴晓莉, 陈小刚, 刘丽旭. 基于MI-SSVEP的脑机接口辅助康复训练对卒中患者上肢运动功能的影响[J]. 中国卒中杂志, 2025, 20(9): 1087-1096.
[4]	栾伟, 魏达, 马超, 张华伟, 李铁民, 彭玉涛, 刘长青. 侵入性迷走神经电刺激联合康复训练治疗缺血性卒中后上肢运动功能障碍的可行性、疗效与安全性研究[J]. 中国卒中杂志, 2025, 20(9): 1097-1103.
[5]	解正绮, 宋晓微. ICAS所致急性缺血性卒中的斑块特征与发病机制关系研究[J]. 中国卒中杂志, 2025, 20(9): 1104-1112.
[6]	柴昌, 胡全忠. 红细胞压积与海拔梯度对中高海拔地区轻型缺血性卒中患者卒中后睡眠障碍的影响研究[J]. 中国卒中杂志, 2025, 20(9): 1113-1120.
[7]	王昶仑, 刘艳君, 艾祁, 吴勤, 占雅静. 优化的cTCD联合cTTE同步检测在右向左分流诊断中的应用与效能评估[J]. 中国卒中杂志, 2025, 20(9): 1121-1130.
[8]	苗连海, 陈继群, 宋诗涛, 杨志勇, 赵辉. 基于GDS-15评价老年卒中后抑郁状态的影响因素及其纵向分析[J]. 中国卒中杂志, 2025, 20(9): 1131-1136.
[9]	赵殿兰, 王燕, 张宏君, 董梦甜, 胡涛. 基于吞咽造影时间学及运动学参数构建卒中后吞咽障碍短期转归不良的列线图预测模型[J]. 中国卒中杂志, 2025, 20(9): 1146-1156.
[10]	贾瑞琪, 翟华筝, 张晨, 汪敬业. 大鼠全脑缺血再灌注损伤后海马CA1区基因表达动态变化研究[J]. 中国卒中杂志, 2025, 20(9): 1157-1166.
[11]	黄媛媛, 周婉冰, 李小燕, 卢政红, 洪小丹. β-羟基丁酸通过TRIB3/Akt/mTOR通路调控蛋白质合成和降解平衡改善卒中相关性肌少症[J]. 中国卒中杂志, 2025, 20(9): 1167-1178.
[12]	侯志凯, 何子骏, 于洮, 沈晨阳, 王嵘, 马宁. 经颈动脉血运重建术治疗颈动脉狭窄1例并文献分析[J]. 中国卒中杂志, 2025, 20(9): 1179-1185.
[13]	陆小燕, 黎佳思. 1例NOTCH3基因双位点突变致CADASIL报道[J]. 中国卒中杂志, 2025, 20(9): 1186-1192.
[14]	濮月华, 董培, 荆京, 董可辉, 李子孝, 龚浠平. 当急性缺血性卒中遇上“栓子雨”[J]. 中国卒中杂志, 2025, 20(9): 1193-1197.
[15]	李欢, 于向明. 急性缺血性卒中DWI-FLAIR不匹配影像学判读研究进展[J]. 中国卒中杂志, 2025, 20(9): 1198-1202.